• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events

Insight on Research

Integrin-mediated T helper 2 cell clustering revealed as key step and potential therapeutic target in allergic immune response

Published on 22 December, 2022

Researchers in Andrew McKenzie’s group, in the LMB’s PNAC Division, have used high-throughput CRISPR screening to identify a role for alpha V beta 3 integrin in IL-13 production which contributes to unwanted inflammation during an asthma or allergic immune response.

DNA replication initiation shapes the evolution and expression of the human genome

Published on 10 November, 2022

One of the universal events in the lifecycle of every cell is the initiation of genome duplication. Julian Sale’s group in the LMB’s PNAC Division have used high-resolution maps of human replication origins to demonstrate the mutagenic properties of DNA replication origins.

Refactoring the genetic code to create organisms protected by a genetic firewall

Published on 24 October, 2022

Jason Chin’s group refactor the genetic code to create genetically isolated organisms which cannot exchange genetic information with naturally-occurring organisms in the environment.

Pathway for making multipass membrane proteins elucidated

Published on 19 October, 2022

New research by the Hegde group and collaborators has used a combination of biochemical and structural approaches to reveal the key factors and steps cells use to embed multipass proteins, such as GPCRs and transporters, into the membrane.

Engineered polymerase enzyme presents new opportunity for quick and efficient modified nucleic acid synthesis

Published on 13 October, 2022

Modified polymerase enzyme produces xeno-nucleic acids efficiently and accurately, opening up possibilities in academic science, pharmaceuticals and biotechnology.

Identification of pathway that enables resistance to tuberculosis

Published on 29 September, 2022

Lalita Ramakrishnan’s group, LMB Cell Biology Division and University of Cambridge Molecular Immunity Unit, has determined that increased metabolism, prompted through mTOR kinase, is a crucial resistance factor against macrophage necrosis during TB infection.

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.